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Abstract—Quantification of neurotransmission Single-Photon 
Emission Computed Tomography (SPECT) studies of the 
dopaminergic system can be used to track, stage and facilita-
te early diagnosis of the disease. The aim of this study was to 
implement QuantiDOPA, a semi-automatic quantification soft-
ware of application in clinical routine to reconstruct and quan-
tify neurotransmission SPECT studies using radioligands which 
bind the dopamine transporter (DAT). To this end, a work-
flow oriented framework for the biomedical imaging (GIMIAS) 
was employed. QuantiDOPA allows the user to perform a semi-
automatic quantification of striatal uptake by following three 
stages: reconstruction, normalization and quantification. Quan-
tiDOPA is a useful tool for semi-automatic quantification in DAT 
SPECT imaging and it has revealed simple and flexible. 
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i. INTRODUCTION 
Parkinson's disease is a neurological disorder associated 
with the loss of dopaminergic neurons. A number of 99mTc-
agents and 123/-agents have been developed for Single-
Photon Emission Computed Tomography (SPECT) imaging 
to study presynaptic dopamine transporter (DAT) binding. 
Quantification of DAT SPECT imaging can be used to dis-
criminate parkinsonian syndromes from other movement dis-
orders. Quantification also facilitates an early diagnosis of the 
disease [1], to follow up its progression [2] and assess the e-
ffects of treatment strategies [3]. 
In clinical routine there is a need for quantification methods 
of DAT SPECT studies. This work deals with the implemen-
tation of QuantiDOPA, a semi-automatic quantification soft-
ware for dopaminergic neurotransmission SPECT studies. 
II. MATERIAL AND METHODS 
This medical application was developed using GIMIAS 
[4], a workflow oriented framework for the biomedical 
imaging and modeling of prototypes in the context of the 
Virtual Physiological Human. It is an open source frame-
work distributed under a BSD license, developed in C++ 
and is based on robust open source libraries such as VTK, 
ITK, MITK, DCMTK, NETGEN and TETGEN, among 
others. 
GIMIAS relies on these libraries for visualization, user 
interaction, data access, image and mesh processing, and 
is designed to easily integrate proprietary algorithms and 
new libraries that broaden the functions of the framework. 
GIMIAS is currently collaborating to develop and adopt stan-
dards that could favour interoperability with similar software 
in the context of the VPHNoE [5]. It also collaborates with 
CTK [6] (Common Toolkit), an international effort to develop 
interoperable software. The goal of GIMIAS is to reduce the 
time needed to develop a clinical prototype. 
Each application implemented on GIMIAS, named 
plug-in, represents an specific process. 
QuantiDOPA is a GIMIAS plug-in whose goal is to ob-
tain from the gammacamera projections the striatum quanti-
fied value. To this end three modules have been developed: 
reconstruction, normalization and quantification. 
A. Reconstruction 
This is an optional module that allows us to standard-
ize the reconstruction protocol of projections from different 
gammacameras. Preprocessing of projections with different 
smoothing Alters can be performed before reconstruction. 
Currently, the reconstruction method is based on the Altered 
backprojection (FBP) algorithm with different smoothing 
Alters. 
B. Normalization 
The reconstructed image is normalized to a SPECT 
template, using two separate steps. In the Arst step, a 9 pa-
rameters 3D afAne transformation is used. The second step 
provides a Ane adjustment of the striatum separately for 
each hemisphere. This is achieved by calculating the local 
correlation coefficient [7] between the reconstructed striatum 
and the SPECT template striatum. This procedure is done for 
each hemisphere. 
The software allows working with a database of different 
SPECT templates. 
C. Quantification 
In order to calculate the mean activity values on the nor-
malized SPECT image, QuantiDOPA allows us to select dif-
ferent regions of interest (ROIs). These ROIs were defined 
following two different approaches which are commonly 
used in nuclear medicine departments: 
• Standardised 3D ROIs map, consisting on an automatic 
volumetric definition of the ROIs based on the morpho-
logy of the striatum according to the Automated Anato-
mical Labelling (AAL) map [8]. 
• 3D cylindrical ROIs [9] placed on the striatum area by 
the user. Eight ROIs are considered, one in the caudate 
and three in the putamen of each hemisphere. In order to 
facilitate cylinders placement, a 2D image consisting of 
the sum of eight central slices of the reconstructed image 
is provided. 
Mean activity values are obtained in ROIs located in the 
striatum and in a background region to obtain the Spe-
cific Uptake Ratio (SUR), a parameter that quantifies the 
specific radioligand uptake in the striatal volume. SUR is 
defined as: 
SUR=^- (1) 
where S and B are the concentration activity in the striatum 
and in a background reference region of non-specific uptake, 
respectively. 
After calculation, the global SUR value in the striatum is 
displayed on the screen. The individual SUR values in each 
ROI allows us to obtain the specific uptake in each of the four 
striatal regions (caudate and putamen for both hemispheres). 
All this information is stored in a data file. 
Figure 1 schematically shows the workflow of the entire 
image processing included in QuantiDOPA. 
in. RESULTS 
QuantiDOPA allows the user to perform a semi-automatic 
quantification of striatal uptake by following the three stages 
mentioned above: 
Fig. 1 Image processing workflow 
A. Reconstruction 
In this module the user only needs to check the parameters 
related to the acquisition and reconstruction, in order to run 
the FBP reconstruction. 
Figure 2 shows and example of a reconstructed image 
using a 2D Butterwoth filter. 
Fig. 2 Reconstructed SPECT image 
B. Normalization 
The image obtained in the previous module is automati-
cally set as an input data for the normalization module. Be-
fore starting the normalization process, the user selects which 
template wants to normalize to. 
Figure 3 shows axial, sagittal, coronal and 3D views of the 
SPECT study displayed in figure 2, after the two normaliza-
tion steps. 
Fig. 3 Axial (top left), sagittal (top right), coronal (bottom left) and 3D 
view (bottom right) of the normalized SPECT image 
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Fig. 4 Axial (top left), sagittal (top right), coronal (bottom left) and 3D 
view (bottom right) of the normalized SPECT image with AALs ROIs 
C. Quantification 
The normalized SPECT image obtained in the previ-
ous stage, is set as the input data of the quantification 
module. 
ROIs based on AALs are automatically placed on the nor-
malization study as shown in figure 4. In the case of cylin-
ders, the user is allowed to slightly modify the positions and 
to change the radius and height. Figure 5 shows a spatially 
normalized SPECT study with cylindrical ROIs on the stria-
tum and the background reference region. The sum of central 
slices of the reconstructed image with cylindrical ROIs is also 
displayed. 
QuantiDORA is being used in a clinical trial to obtain 
SUR values from healthy volunteers in six Spanish 
hospitals. 
iv. CONCLUSIONS 
QuantiDORA is a useful tool for semi-automatic quantifi-
cation in DAT SPECT imaging and it has revealed simple and 
flexible. 
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